Cardiac Monitoring & Cardiac Rhythm Management Devices Market: Global Forecast until 2022

The cardiac monitoring and cardiac rhythm management devices market is estimated to rise at a compound annual growth rate of 4.00 percent during the forecast period.

The cardiac monitoring and cardiac rhythm management devices market is forecasted to reach ~$25.1M by 2022 from ~$20.7M in 2017, at a compound annual growth rate (CAGR) of 4.0% during the forecast horizon. The scope of the report includes cardiac monitoring and cardiac rhythm management used for the continuous monitoring, detection, and treatment of heart activities and abnormal heart rhythm.

Growing incidence of cardiovascular diseases and technological improvements in devices are the factors anticipated to propel the increase of the market. Nevertheless, price sensitivity and limited reimbursements for remote cardiac monitoring devices are anticipated to restrain the increase of the CM & CRM devices market.

ECG devices held the most important share of the cardiac monitoring devices market in 2017

Established on products, the cardiac monitoring devices market is categorized into ECG devices, implantable loop recorders, cardiac output monitors, mobile cardiac telemetry, and smart wearable ECG monitors.The ECG devices segment recorded for the largest market share in 2017.

The important share of this segment can primarily be attributed to the rising incidence of cardiovascular diseases, the wide application of ECG devices in CVD management, development of technologically advanced devices, and government actions.

North America (NA) recorded for the biggest share of the market in 2017

On the basis of area, the CM & CRM devices market is divided into north america, EU, Asia continent, and RoW.North America continent recorded for the biggest share of the CM & CRM devices market in 2017.

The big share of this regional segment can be accredited to the increase in the geriatric population and the subsequent increase in the prevalence of cardiovascular diseases, high accessibility to advanced technologies, growing development of innovative and technologically advanced products, and rising healthcare expenditure in the territory.

Break-up profile of primaries:

• By Type of company- tier 1 - 42.0 percent, Tier 2 - 37.0 percent and Tier 3 - 21.0 percent

• By Designation-C-level - 34.0 percent, D-level - 42.0 percent and Others - 24.0 percent

• By Region-North America - 32.0 percent, Europe (EU) - 30.0 percent, Asia area - 24.0 percent, and rest of the world - 14.0 percent

Main top actors in the cardiac monitoring and cardiac rhythm management devices market contain Medtronic, Abbott, Boston Scientific, BIOTRONIK, GE Healthcare (GE subsidiary), and Philips Healthcare (Philips's subsidiary).

Segment Research

In this business report, the cardiac monitoring and cardiac rhythm management devices market is broken down by products, final user, and area. The industry report offers a in-depth overview of the main drivers, opportunities, alternatives, and restraining factors impacting the cardiac monitoring and cardiac rhythm management devices market together with the estimates and forecasts of the revenue.

Why acquiring this study can help you:

This study furnishes highlights on the following points:

• Market Uptake: Exhaustive data on portfolios provided by the top actors in the cardiac monitoring and cardiac rhythm management devices market. The analysis examines the sector by product, end-user, and area

• Product Development/Innovative products: In-depth understanding on up-on-coming technologies, analysis & growth activities, and launches of new product in the cardiac monitoring and cardiac rhythm management devices market

• Market Development: Highlighted information about profitable emerging sectors - the market research examines the industries for cardiac monitoring and cardiac rhythm management devices across localities

• industry diversification: Complete information about recent products, untapped areas, and recent evolutions in the cardiac monitoring and cardiac rhythm management devices market

• opposing assessment: Detailed assessment of strategies, products, and manufacturing capabilities of the main actors in the cardiac monitoring and cardiac rhythm management devices market